Charles River Laboratories International (CRL) EBT Margin (2009 - 2025)

Charles River Laboratories International's EBT Margin history runs 17 years deep, the most recent figure standing at 29.58% for Q4 2025.

• In Q4 2025, EBT Margin fell 796.0% year-over-year to 29.58%; the TTM figure through Dec 2025 stood at 2.48% (down 478.0% YoY), while the FY2025 annual figure was 2.48%, down 478.0% from the prior year.
• EBT Margin was 29.58% for Q4 2025 at Charles River Laboratories International, down from 8.68% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 22.27% in Q4 2022 to a low of 29.58% in Q4 2025.
• Historically, EBT Margin has averaged 8.52% across 5 years, with a median of 11.89% in 2022.
• The sharpest annual moves came in 2022 and 2024: EBT Margin jumped 419 bps in 2022, then slumped 4222 bps in 2024.
• A 5-year view of EBT Margin shows it stood at 18.08% in 2021, then gained by 23 bps to 22.27% in 2022, then declined by 8 bps to 20.59% in 2023, then sank by 205 bps to 21.62% in 2024, then sank by 37 bps to 29.58% in 2025.
• The last three EBT Margin figures came in at 29.58% (Q4 2025), 8.68% (Q3 2025), and 6.92% (Q2 2025), per Business Quant data.